WASHINGTON, Jan. 25 /PRNewswire-USNewswire/ -- FDA is alerting consumers to an unsafe, counterfeit version of the weight-loss drug Alli sold over the Internet.
FDA lab tests showed that the counterfeit Alli has a different active ingredient, a stimulant found in a prescription weight-loss drug. People using the counterfeit Alli may be taking three times the usual daily dose of the stimulant if they are following the dosing directions for Alli.
This excessive amount of the stimulant may lead to stroke or heart attack in people who have a history of cardiovascular disease. Even healthy people can experience symptoms, including heart palpitations.
To read the full FDA Consumer Update article, see FDA Warns Consumers About Unsafe Counterfeit Alli at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm198557.htm
Subscribe to receive e-mail notices of new FDA Consumer Updates at: https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
View the FDA Consumer Update RSS feed at: http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml
FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to: email@example.com.
Media contact: Jason Brodsky at 301-827-6251
SOURCE U.S. Food and Drug Administration